These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31005704)

  • 1. High performance liquid chromatography (HPLC) based direct and simultaneous estimation of excipients in biopharmaceutical products.
    Hebbi V; Chattopadhyay S; Rathore AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():118-126. PubMed ID: 31005704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enablement of the direct analysis of excipients in monoclonal antibody formulations through the incorporation of a wide pore C18 protein trap with hydrophilic interaction liquid chromatography.
    Huang JZ; Lin S; Huang Z; Bolgar MS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():131-135. PubMed ID: 29059588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
    He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
    J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Small-Scale Process for Predicting Donnan and Volume Exclusion Effects During Ultrafiltration/Diafiltration Process Development.
    Abel J; Kosky A; Ball N; Bacon H; Kaushik R; Kleemann GR
    J Pharm Sci; 2018 May; 107(5):1296-1303. PubMed ID: 29339134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theoretical analysis of excipient concentrations during the final ultrafiltration/diafiltration step of therapeutic antibody.
    Miao F; Velayudhan A; DiBella E; Shervin J; Felo M; Teeters M; Alred P
    Biotechnol Prog; 2009; 25(4):964-72. PubMed ID: 19569193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations.
    Thakur G; Hebbi V; Rathore AS
    Int J Pharm; 2021 May; 600():120456. PubMed ID: 33711473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of amlodipine and aliskren in tablets by high-performance liquid chromatography.
    Özdemir FA; Akyüz A
    J Chromatogr Sci; 2014 Aug; 52(7):685-90. PubMed ID: 23839804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic model of pH and excipient concentration during ultrafiltration and diafiltration processes of therapeutic antibodies.
    Ladwig JE; Zhu X; Rolandi P; Hart R; Robinson J; Rydholm A
    Biotechnol Prog; 2020 Sep; 36(5):e2993. PubMed ID: 32185869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting diafiltration solution compositions for final ultrafiltration/diafiltration steps of monoclonal antibodies.
    Teeters M; Bezila D; Benner T; Alfonso P; Alred P
    Biotechnol Bioeng; 2011 Jun; 108(6):1338-46. PubMed ID: 21328314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying methionine sulfoxide in therapeutic protein formulation excipients as sensitive oxidation marker.
    Fevre A; Kiessig S; Bonnington L; Olaf Stracke J; Bulau P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1189():123092. PubMed ID: 35026663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial coupling of ion-exchange and size-exclusion chromatography to determine aggregation levels in mAbs in the presence of a proteinaceous excipient, recombinant human serum albumin.
    Weisbjerg PL; Caspersen MB; Cook K; Van De Weert M
    J Pharm Sci; 2015 Feb; 104(2):548-56. PubMed ID: 25447946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability.
    Sarin D; Krishna K; Nejadnik MR; Suryanarayanan R; Rathore AS
    Mol Pharm; 2024 Apr; 21(4):1872-1883. PubMed ID: 38422397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid and sensitive bioanalytical stability-indicating method for quantification of talinolol, a selective β1 adrenoceptor antagonist in lipid based formulations using ultrafast UHPLC systems.
    Mohsin K; Al-Qahtani S; Alanazi FK
    Acta Pol Pharm; 2014; 71(5):737-45. PubMed ID: 25362802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of trace levels of hydrogen peroxide in crospovidone and a pharmaceutical product using high performance liquid chromatography with coulometric detection.
    Yue H; Bu X; Huang MH; Young J; Raglione T
    Int J Pharm; 2009 Jun; 375(1-2):33-40. PubMed ID: 19481688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Online Coupling of Size Exclusion Chromatography to Capillary Enhanced Raman Spectroscopy for the Analysis of Proteins and Biopharmaceutical Drug Products.
    Thissen J; Klassen MD; Constantinidis P; Hacker MC; Breitkreutz J; Teutenberg T; Fischer B
    Anal Chem; 2023 Dec; 95(48):17868-17877. PubMed ID: 38050672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On-line coupling of hydrophobic interaction column with reverse phase column -charged aerosol detector/mass spectrometer to characterize polysorbates in therapeutic protein formulations.
    He Y; Brown P; Bailey Piatchek MR; Carroll JA; Jones MT
    J Chromatogr A; 2019 Feb; 1586():72-81. PubMed ID: 30551943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column.
    Pérez-Robles R; Cuadros-Rodríguez L; Salmerón-García A; Navas N
    J Pharm Biomed Anal; 2018 Sep; 159():437-448. PubMed ID: 30071467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations.
    Yu Z; Moomaw JF; Thyagarajapuram NR; Geng SB; Bent CJ; Tang Y
    Biotechnol Prog; 2021 Mar; 37(2):e3106. PubMed ID: 33289341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.